1 active trials 0 recruiting 1 disease areas
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06335173 | A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With… | Alzheimer Disease | Active, Not Recruiting | 2025-10-27 |